CD4 and tuberculosis: DCreg developed on lung stroma isolated from mice of I/St and B6 inbred strains (genetically TB-hyper-susceptible and relatively resistant, respectively) inhibited the response of isogenic CD4+ T-cell lines specific to mycobacterial antigens in a dose-dependent manner.